Other investigators on the model of hepatocellular carcinoma (HCC) demonstrated, that Robo1 expression promoted tumor angiogenesis and may be considered as an alternative target for anti-angiogenesis treatment [50]. This evidence concerns the gene ROBO1 and neoplasm.